Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Venous Thrombosis

  Free Subscription


Articles published in Thromb Res

Retrieve available abstracts of 214 articles:
HTML format
Text format



Single Articles


    March 2017
  1. RUHLE F, Stoll M
    Genetic factors in pediatric venous thromboembolism.
    Thromb Res. 2017;151 Suppl 1:S97-S99.
    PubMed     Text format     Abstract available


  2. BARCO S, Konstantinides SV
    Risk-adapted management of pulmonary embolism.
    Thromb Res. 2017;151 Suppl 1:S92-S96.
    PubMed     Text format     Abstract available


  3. TROMEUR C, van der Pol LM, Klok FA, Couturaud F, et al
    Pitfalls in the diagnostic management of pulmonary embolism in pregnancy.
    Thromb Res. 2017;151 Suppl 1:S86-S91.
    PubMed     Text format     Abstract available


  4. BLANCO-MOLINA A, Trujillo-Santos J, Pesavento R, Rosa V, et al
    Outcome after discontinuing anticoagulant therapy in women with venous thromboembolism during hormonal use.
    Thromb Res. 2017;151 Suppl 1:S6-S10.
    PubMed     Text format     Abstract available


  5. MARTIN-MARTOS F, Trujillo-Santos J, Del Toro J, Bura-Riviere A, et al
    Gender differences in patients with venous thromboembolism and five common sites of cancer.
    Thromb Res. 2017;151 Suppl 1:S16-S20.
    PubMed     Text format     Abstract available


  6. TZORAN I, Papadakis E, Brenner B, Valle R, et al
    Gender-related differences in the outcome of patients with venous thromboembolism and thrombophilia.
    Thromb Res. 2017;151 Suppl 1:S11-S15.
    PubMed     Text format     Abstract available


  7. MOUSTAFA F, Fernandez S, Fernandez-Capitan C, Nieto JA, et al
    Uterine bleeding during anticoagulation in women with venous thromboembolism.
    Thromb Res. 2017;151 Suppl 1:S1-S5.
    PubMed     Text format     Abstract available


    February 2017
  8. VAN ES N, Wells PS, Carrier M
    Bleeding risk in patients with unprovoked venous thromboembolism: A critical appraisal of clinical prediction scores.
    Thromb Res. 2017;152:52-60.
    PubMed     Text format     Abstract available


  9. WILTS IT, Le Gal G, Den Exter PL, Van Es J, et al
    Performance of the age-adjusted cut-off for D-dimer in patients with cancer and suspected pulmonary embolism.
    Thromb Res. 2017;152:49-51.
    PubMed     Text format     Abstract available


  10. THEBERGE I, Bowdridge J, Forgie MA, Carrier M, et al
    Rivaroxaban shows promise as effective therapy for cancer patients with venous thromboembolic disease.
    Thromb Res. 2017;152:4-6.
    PubMed     Text format    


    January 2017
  11. KHORANA AA, Francis CW, Kuderer NM, Carrier M, et al
    Dalteparin thromboprophylaxis in cancer patients at high risk for venous thromboembolism: A randomized trial.
    Thromb Res. 2017 Jan 26. pii: S0049-3848(17)30020.
    PubMed     Text format     Abstract available


  12. PUURUNEN MK, Hwang SJ, O'Donnell CJ, Tofler G, et al
    Platelet function as a risk factor for venous thromboembolism in the Framingham Heart Study.
    Thromb Res. 2017;151:57-62.
    PubMed     Text format     Abstract available


  13. COWAN LT, Lutsey PL, Pankow JS, Cushman M, et al
    Hospitalization with infection and incident venous thromboembolism: The ARIC study.
    Thromb Res. 2017;151:74-78.
    PubMed     Text format     Abstract available


  14. COYLE K, Carrier M, Lazo-Langner A, Shivakumar S, et al
    Cost effectiveness of the addition of a comprehensive CT scan to the abdomen and pelvis for the detection of cancer after unprovoked venous thromboembolism.
    Thromb Res. 2017;151:67-71.
    PubMed     Text format     Abstract available


  15. KUO TH, Li HY, Lin SH
    Acute kidney injury and risk of deep vein thrombosis and pulmonary embolism in Taiwan: A nationwide retrospective cohort study.
    Thromb Res. 2017;151:29-35.
    PubMed     Text format     Abstract available


  16. ENDE-VERHAAR YM, Huisman MV, Klok FA
    To screen or not to screen for chronic thromboembolic pulmonary hypertension after acute pulmonary embolism.
    Thromb Res. 2017;151:1-7.
    PubMed     Text format     Abstract available


    December 2016
  17. ZOLLER B, Li X, Ohlsson H, Sundquist J, et al
    Seasonal variation of pulmonary embolism and age dependence.
    Thromb Res. 2016;150:76-77.
    PubMed     Text format    


  18. ROSS JA, Miller MM, Rojas Hernandez CM
    Comparative effectiveness and safety of direct oral anticoagulants (DOACs) versus conventional anticoagulation for the treatment of cancer-related venous thromboembolism: A retrospective analysis.
    Thromb Res. 2016;150:86-89.
    PubMed     Text format     Abstract available


  19. VAN ES N, Franke VF, Middeldorp S, Wilmink JW, et al
    The Khorana score for the prediction of venous thromboembolism in patients with pancreatic cancer.
    Thromb Res. 2016;150:30-32.
    PubMed     Text format     Abstract available


  20. SWIER N, Versteeg HH
    Reciprocal links between venous thromboembolism, coagulation factors and ovarian cancer progression.
    Thromb Res. 2016;150:8-18.
    PubMed     Text format     Abstract available


  21. OZCAN CETIN EH, Cetin MS, Canpolat U, Akdi A, et al
    Platelet-to-lymphocyte ratio as a novel marker of in-hospital and long-term adverse outcomes among patients with acute pulmonary embolism: A single center large-scale study.
    Thromb Res. 2016;150:33-40.
    PubMed     Text format     Abstract available


  22. PIOVELLA F, Iosub DI
    Extended non-vitamin K antagonist oral anticoagulation therapy for prevention of recurrent venous thromboembolism.
    Thromb Res. 2016 Dec 7. pii: S0049-3848(16)30645.
    PubMed     Text format     Abstract available


  23. GARCIA-HORTON A, Kovacs MJ, Abdulrehman J, Taylor JE, et al
    Impact of thrombophilia screening on venous thromboembolism management practices.
    Thromb Res. 2016;149:76-80.
    PubMed     Text format     Abstract available


    November 2016
  24. OLIE V, Bonaldi C
    Pulmonary embolism: Does the seasonal effect depend on age? A 12-year nationwide analysis of hospitalization and mortality.
    Thromb Res. 2016 Nov 30. pii: S0049-3848(16)30640.
    PubMed     Text format     Abstract available


  25. LIN CL, Lin CL, Tzeng SL, Chung WS, et al
    Aplastic anemia and risk of deep vein thrombosis and pulmonary embolism: A nationwide cohort study.
    Thromb Res. 2016;149:70-75.
    PubMed     Text format     Abstract available


  26. BURWEN DR, Wu C, Cirillo D, Rossouw JE, et al
    Venous thromboembolism incidence, recurrence, and mortality based on Women's Health Initiative data and Medicare claims.
    Thromb Res. 2016;150:78-85.
    PubMed     Text format     Abstract available


    October 2016
  27. PLANQUETTE B, Ferre A, Peron J, Vial-Dupuy A, et al
    Residual pulmonary vascular obstruction and recurrence after acute pulmonary embolism. A single center cohort study.
    Thromb Res. 2016;148:70-75.
    PubMed     Text format     Abstract available


  28. ALEXANDER M, Burbury K
    A systematic review of biomarkers for the prediction of thromboembolism in lung cancer - Results, practical issues and proposed strategies for future risk prediction models.
    Thromb Res. 2016;148:63-69.
    PubMed     Text format     Abstract available


  29. BEYER-WESTENDORF J
    Letter to the Editor "Gender related aspects of bleeding with rivaroxaban in venous thromboembolism - Potential for pitfalls": A comment to "Impact of gender on safety and efficacy of rivaroxaban in adolescents & young adults with venous thromboem
    Thromb Res. 2016 Oct 26. pii: S0049-3848(16)30601.
    PubMed     Text format    


  30. ZOLLER B, Ohlsson H, Sundquist J, Sundquist K, et al
    A sibling based design to quantify genetic and shared environmental effects of venous thromboembolism in Sweden.
    Thromb Res. 2016 Oct 20. pii: S0049-3848(16)30587.
    PubMed     Text format     Abstract available


  31. KANG J, Lee JS, Lee JH, Lee KM, et al
    Recurrent pulmonary embolism during dabigatran treatment in a patient with immune thrombocytopenic purpura.
    Thromb Res. 2016;148:23-24.
    PubMed     Text format    


  32. MELANCON T, Bivona C, Klenke S, Rockey M, et al
    Comparison of postoperative venous thromboembolism incidence in gastrointestinal and gynecologic solid tumors.
    Thromb Res. 2016;147:104-107.
    PubMed     Text format     Abstract available


  33. RABINOVICH E, Bartholomew JR, Wilks ML, Tripp BL, et al
    Centralizing care of cancer-associated thromboembolism: The Cleveland Clinic experience.
    Thromb Res. 2016;147:102-103.
    PubMed     Text format    


  34. PIRAN S, Schulman S
    Incidence and risk factors for venous thromboembolism in patients with acute spinal cord injury: A retrospective study.
    Thromb Res. 2016;147:97-101.
    PubMed     Text format     Abstract available


    September 2016
  35. CORRAINI P, Ording AG, Henderson VW, Szepligeti S, et al
    Cancer, other comorbidity, and risk of venous thromboembolism after stroke: a population-based cohort study.
    Thromb Res. 2016;147:88-93.
    PubMed     Text format     Abstract available


  36. VINSON DR, Ballard DW, Mark DG, Huang J, et al
    Risk stratifying emergency department patients with acute pulmonary embolism: Does the simplified Pulmonary Embolism Severity Index perform as well as the original?
    Thromb Res. 2016;148:1-8.
    PubMed     Text format     Abstract available


  37. DEMELO-RODRIGUEZ P, Postigo-Esteban A, Garcia-Fernandez-Bravo I, Agud M, et al
    Evaluation of the SAMe-TT2R2 score to predict the quality of anticoagulation control in a cohort of patients with venous thromboembolism treated with vitamin K antagonists.
    Thromb Res. 2016;147:58-60.
    PubMed     Text format     Abstract available


  38. VOILS SA, Lemon SJ, Jordan J, Riley P, et al
    Early thrombin formation capacity in trauma patients and association with venous thromboembolism.
    Thromb Res. 2016;147:13-15.
    PubMed     Text format     Abstract available


  39. BLEKER SM, Beenen LF, Di Nisio M, van Es N, et al
    Incidental pulmonary embolism in cancer patients: Interobserver agreement on the diagnosis and extent with a focus on distal clots.
    Thromb Res. 2016;147:46-51.
    PubMed     Text format     Abstract available


  40. ARACHCHILLAGE D, Reynolds R, Devey T, Maclean R, et al
    Effect of extremes of body weight on drug level in patient treated with standard dose of rivaroxaban for venous thromboembolism; real life experience.
    Thromb Res. 2016;147:32-35.
    PubMed     Text format    


  41. KRAUSE M, Henningsen A, Torge A, Juhl D, et al
    Impact of gender on safety and efficacy of Rivaroxaban in adolescents & young adults with venous thromboembolism.
    Thromb Res. 2016 Sep 13. pii: S0049-3848(16)30542.
    PubMed     Text format    


    August 2016
  42. PETCH S, Norris L, O'Toole S, Gleeson N, et al
    Peri operative venous thromboembolism prophylaxis in gynaecological cancer patients. A survey of current practice.
    Thromb Res. 2016;145:126-128.
    PubMed     Text format    


    July 2016
  43. GROSSE SD
    Cost-of-illness models for venous thromboembolism: One size does not fit all.
    Thromb Res. 2016;145:65-66.
    PubMed     Text format    


  44. HOFMANN E, Limacher A, Mean M, Kucher N, et al
    Echocardiography does not predict mortality in hemodynamically stable elderly patients with acute pulmonary embolism.
    Thromb Res. 2016;145:67-71.
    PubMed     Text format     Abstract available


  45. KHORANA AA, Yannicelli D, McCrae KR, Milentijevic D, et al
    Evaluation of US prescription patterns: Are treatment guidelines for cancer-associated venous thromboembolism being followed?
    Thromb Res. 2016;145:51-53.
    PubMed     Text format     Abstract available


  46. PUURUNEN MK, Enserro D, Xanthakis V, Larson MG, et al
    Biomarkers for the prediction of venous thromboembolism in the community.
    Thromb Res. 2016;145:34-39.
    PubMed     Text format     Abstract available


    June 2016
  47. PUURUNEN MK, Gona PN, Larson MG, Murabito JM, et al
    Epidemiology of venous thromboembolism in the Framingham Heart Study.
    Thromb Res. 2016;145:27-33.
    PubMed     Text format     Abstract available


  48. MAHAN CE, Barco S, Spyropoulos AC
    Cost-of-illness model for venous thromboembolism.
    Thromb Res. 2016 Jun 23. pii: S0049-3848(16)30460.
    PubMed     Text format    


  49. KUBOTA Y, McAdams-DeMarco M, Folsom AR
    Serum uric acid, gout, and venous thromboembolism: The atherosclerosis risk in communities study.
    Thromb Res. 2016;144:144-148.
    PubMed     Text format     Abstract available


  50. ROUZAUD D, Alexandra JF, Chauchard M, Delon M, et al
    Incidental venous thromboembolism diagnosed in patients admitted with a first venous thromboembolism: Frequency and clinical significance (an observational study).
    Thromb Res. 2016;144:116-118.
    PubMed     Text format    


  51. CUSHMAN M, O'Meara ES, Heckbert SR, Zakai NA, et al
    Body size measures, hemostatic and inflammatory markers and risk of venous thrombosis: The Longitudinal Investigation of Thromboembolism Etiology.
    Thromb Res. 2016;144:127-132.
    PubMed     Text format     Abstract available


  52. BLEKER SM, Buchmuller A, Chauleur C, Ainle FN, et al
    Low-molecular-weight heparin to prevent recurrent venous thromboembolism in pregnancy: Rationale and design of the Highlow study, a randomised trial of two doses.
    Thromb Res. 2016;144:62-68.
    PubMed     Text format     Abstract available


  53. AMBRUS DB, Reisman JI, Rose AJ
    The impact of new-onset cancer among veterans who are receiving warfarin for atrial fibrillation and venous thromboembolism.
    Thromb Res. 2016;144:21-26.
    PubMed     Text format     Abstract available


    May 2016
  54. BAUERSACHS R
    Non-vitamin K antagonist oral anticoagulants for the prevention of recurrent venous thromboembolism.
    Thromb Res. 2016;144:12-20.
    PubMed     Text format     Abstract available


  55. GARCIA-OLIVARES P, Guerrero JE, Keough E, Galdos P, et al
    Clinical factors associated with inappropriate prophylaxis of venous thromboembolic disease in critically ill patients. A single day cross-sectional study.
    Thromb Res. 2016;143:111-117.
    PubMed     Text format     Abstract available


  56. CARMONA-BAYONAS A, Font C, Jimenez-Fonseca P, Fenoy F, et al
    On the necessity of new decision-making methods for cancer-associated, symptomatic, pulmonary embolism.
    Thromb Res. 2016;143:76-85.
    PubMed     Text format     Abstract available


  57. BARNES GD, Izzo B, Conte ML, Chopra V, et al
    Use of decision aids for shared decision making in venous thromboembolism: A systematic review.
    Thromb Res. 2016;143:71-75.
    PubMed     Text format     Abstract available


  58. SANFILIPPO KM, Wang TF, Gage BF, Luo S, et al
    Incidence of venous thromboembolism in patients with non-Hodgkin lymphoma.
    Thromb Res. 2016;143:86-90.
    PubMed     Text format     Abstract available


    April 2016
  59. RODGER MA, Phillips P, Kahn SR, Bates S, et al
    Low molecular weight heparin to prevent postpartum venous thromboembolism: A pilot study to assess the feasibility of a randomized, open-label trial.
    Thromb Res. 2016;142:17-20.
    PubMed     Text format    


  60. KRISTOFFERSEN AH, Ajzner E, Rogic D, Sozmen EY, et al
    Is D-dimer used according to clinical algorithms in the diagnostic work-up of patients with suspicion of venous thromboembolism? A study in six European countries.
    Thromb Res. 2016;142:1-7.
    PubMed     Text format     Abstract available


  61. MENAPACE LA, McCrae KR, Khorana AA
    Predictors of recurrent venous thromboembolism and bleeding on anticoagulation.
    Thromb Res. 2016;140 Suppl 1:S93-8.
    PubMed     Text format     Abstract available


  62. GHESHMY A, Carrier M
    Venous thromboembolism and occult cancer: impact on clinical practice.
    Thromb Res. 2016;140 Suppl 1:S8-S11.
    PubMed     Text format     Abstract available


  63. LIEBMAN HA, O'Connell C
    Incidental venous thromboembolic events in cancer patients: what we know in 2016.
    Thromb Res. 2016;140 Suppl 1:S18-20.
    PubMed     Text format     Abstract available


  64. BRUNSON A, Ho G, White R, Wun T, et al
    Inferior vena cava filters in patients with cancer and venous thromboembolism (VTE): patterns of use and outcomes.
    Thromb Res. 2016;140 Suppl 1:S132-41.
    PubMed     Text format     Abstract available


  65. ROMUALDI E, Ageno W
    Management of recurrent venous thromboembolism in cancer patients.
    Thromb Res. 2016;140 Suppl 1:S128-31.
    PubMed     Text format     Abstract available


  66. RIEDL J, Kaider A, Marosi C, Prager G, et al
    PO-63 - Exhausted platelets in cancer patients with high risk of venous thromboembolism and poor prognosis.
    Thromb Res. 2016;140 Suppl 1:S199-200.
    PubMed     Text format     Abstract available


  67. WELLS PS, Theberge IA, Bowdridge JC, Forgie MA, et al
    PO-41 - Rivaroxaban is effective therapy for high risk cancer patients with venous thromboembolic disease.
    Thromb Res. 2016;140 Suppl 1:S191-2.
    PubMed     Text format     Abstract available


  68. MANCUSO A, Vedovati MC, Pierpaoli L, Paliani U, et al
    PO-40 - Real-life use of non-vitamin k antagonist oral anticoagulants in patients with cancer associated venous thromboembolism: data from a prospective cohort.
    Thromb Res. 2016;140 Suppl 1:S191.
    PubMed     Text format     Abstract available


  69. WILTS IT, Le Gal G, den Exter PL, van Es J, et al
    PO-29 - Age-adjusted D-dimer cutoff level increases the number of cancer patients in who pulmonary embolism can be safely excluded without CT-PA imaging: The ADJUST-PE cancer substudy.
    Thromb Res. 2016;140 Suppl 1:S187.
    PubMed     Text format     Abstract available


  70. VAN ES N, van der Hulle T, van Es J, den Exter PL, et al
    PO-07 - Excluding pulmonary embolism in cancer patients using the Wells rule and age-adjusted D-dimer testing: an individual patient data meta-analysis.
    Thromb Res. 2016;140 Suppl 1:S179.
    PubMed     Text format     Abstract available


  71. CORRAINI P, Ording AG, Henderson VW, Szepligeti S, et al
    PO-06 - Cancer and the risk of venous thromboembolism in stroke patients.
    Thromb Res. 2016;140 Suppl 1:S178.
    PubMed     Text format     Abstract available


  72. ADRIAN SG, de Castro EM, Olmos VP, Martin MN, et al
    PO-05 - Incidence of venous thromboembolism (VTE) in bile duct tumors (BDT) treated with chemotherapy in ambulatory setting.
    Thromb Res. 2016;140 Suppl 1:S178.
    PubMed     Text format     Abstract available


  73. SANTI RM, Ceccarelli M, Catania G, Monagheddu C, et al
    PO-03 - Khorana score and histotype predict the incidence of early venous thromboembolism (VTE) in Non Hodgkin Lymphoma (NHL). A pooled data analysis of twelve clinical trials of Fondazione Italiana Linfomi (FIL).
    Thromb Res. 2016;140 Suppl 1:S177.
    PubMed     Text format     Abstract available


  74. MARTIN AJ, Ziyatdinov A, Rubio VC, Olmos VP, et al
    PO-04 - A new genetic risk score for predicting venous thromboembolic events in cancer patients receiving chemotherapy.
    Thromb Res. 2016;140 Suppl 1:S177-8.
    PubMed     Text format     Abstract available


  75. KONIGSBRUGGE O, Riedl J, Grilz E, Wiltschke C, et al
    PO-01 - Congestive heart failure is an independent risk factor for venous thromboembolism and mortality in cancer patients.
    Thromb Res. 2016;140 Suppl 1:S176.
    PubMed     Text format     Abstract available


  76. PIATEK CI, Tagawa ST, Wei-Tsai D, Hanna D, et al
    OC-14 - Baseline D-dimer levels are predictive of recurrent venous thromboembolism (VTE) at 6 months in cancer patients with VTE treated with tinzaparin.
    Thromb Res. 2016;140 Suppl 1:S174.
    PubMed     Text format     Abstract available


  77. COSMI B, Legnani C, Ghirarduzzi A, De Micheli V, et al
    OC-15 - Risk factors for cancer development after idiopathic venous thromboembolism.
    Thromb Res. 2016;140 Suppl 1:S174.
    PubMed     Text format     Abstract available


  78. ROSS JA, Miller M, Hernandez CR
    OC-13 - Safe and effective use of direct oral anticoagulants (DOAC) versus conventional anticoagulation for the treatment of cancer-related venous thromboembolism.
    Thromb Res. 2016;140 Suppl 1:S173-4.
    PubMed     Text format     Abstract available


  79. PETCH S, Norris LA, O'Toole SA, Gleeson N, et al
    OC-12 - Peri operative venous thromboembolism prophylaxis in gynaecological cancer patients. A survey of current practice.
    Thromb Res. 2016;140 Suppl 1:S173.
    PubMed     Text format     Abstract available


  80. YOUNG A, Phillips J, Hancocks H, Hill C, et al
    OC-11 - Anticoagulation therapy in selected cancer patients at risk of recurrence of venous thromboembolism.
    Thromb Res. 2016;140 Suppl 1:S172-3.
    PubMed     Text format     Abstract available


  81. ANTIC D, Milic N, Todorovic M, Bila J, et al
    OC-07 - Decoding risk for thromboembolic events in lymphoma patients.
    Thromb Res. 2016;140 Suppl 1:S171.
    PubMed     Text format     Abstract available


  82. ALEXANDER M, Wolfe R, Ball D, Manser R, et al
    OC-05 - D-Dimer, fibrinogen and TEG-MA predict thromboembolism in non-small cell lung cancer - interim results from a prospective cohort study.
    Thromb Res. 2016;140 Suppl 1:S170.
    PubMed     Text format     Abstract available


  83. NAVI BB, Reiner AS, Kamel H, Iadecola C, et al
    OC-02 - Risk of arterial thromboembolism in patients with breast cancer.
    Thromb Res. 2016;140 Suppl 1:S169.
    PubMed     Text format     Abstract available


    March 2016
  84. PARK MS, Perkins SE, Spears GM, Ashrani AA, et al
    Risk factors for venous thromboembolism after acute trauma: A population-based case-cohort study.
    Thromb Res. 2016;144:40-45.
    PubMed     Text format     Abstract available


  85. MARTINELLI I, Maino A, Abbattista M, Bucciarelli P, et al
    Duration of oral contraceptive use and the risk of venous thromboembolism. A case-control study.
    Thromb Res. 2016;141:153-157.
    PubMed     Text format     Abstract available


  86. ISHOLA T, Kirk SE, Guffey D, Voigt K, et al
    Risk factors and co-morbidities in adolescent thromboembolism are different than those in younger children.
    Thromb Res. 2016;141:178-182.
    PubMed     Text format     Abstract available


  87. SAMUELSON BT, Gernsheimer T, Estey E, Garcia DA, et al
    Variability in management of hematologic malignancy patients with venous thromboembolism and chemotherapy-induced thrombocytopenia.
    Thromb Res. 2016;141:104-105.
    PubMed     Text format    


  88. RATASVUORI M, Lassila R, Laitinen M
    Venous thromboembolism after surgical treatment of non-spinal skeletal metastases - An underdiagnosed complication.
    Thromb Res. 2016;141:124-128.
    PubMed     Text format     Abstract available


  89. PRANDONI P, Noventa F, Lensing AW, Prins MH, et al
    Post-thrombotic syndrome and the risk of subsequent recurrent thromboembolism.
    Thromb Res. 2016;141:91-92.
    PubMed     Text format    


  90. YU TT, Nelson J, Streiff MB, Lanzkron S, et al
    Risk factors for venous thromboembolism in adults with hemoglobin SC or Sbeta thalassemia genotypes.
    Thromb Res. 2016;141:35-38.
    PubMed     Text format     Abstract available


  91. BORGDORFF P, Tangelder GJ
    Arguments favoring low versus high dose aspirin in the prophylaxis of venous thromboembolism.
    Thromb Res. 2016;139:121-4.
    PubMed     Text format    


  92. FOLSOM AR, Tang W, George KM, Heckbert SR, et al
    Prospective study of gamma' fibrinogen and incident venous thromboembolism: The Longitudinal Investigation of Thromboembolism Etiology (LITE).
    Thromb Res. 2016;139:44-9.
    PubMed     Text format     Abstract available


  93. ASHRANI AA, Gullerud RE, Petterson TM, Marks RS, et al
    Risk factors for incident venous thromboembolism in active cancer patients: A population based case-control study.
    Thromb Res. 2016;139:29-37.
    PubMed     Text format     Abstract available


  94. BOVA C, Bianco A, Mascaro V, Nobile CG, et al
    Extended anticoagulation and mortality in venous thromboembolism. A meta-analysis of six randomized trials.
    Thromb Res. 2016;139:22-8.
    PubMed     Text format     Abstract available


  95. PRASAD M, McBane R, Reriani M, Lerman LO, et al
    Coronary endothelial dysfunction is associated with increased risk of venous thromboembolism.
    Thromb Res. 2016;139:17-21.
    PubMed     Text format     Abstract available


    February 2016
  96. LABRADOR J, Gonzalez-Rivero J, Monroy R, Lozano FS, et al
    Management patterns and outcomes in symptomatic venous thromboembolism following allogeneic hematopoietic stem cell transplantation. A 15-years experience at a single center.
    Thromb Res. 2016 Feb 18. pii: S0049-3848(16)30043.
    PubMed     Text format     Abstract available


  97. ROZJABEK HM, Coleman CI, Weeda ER, Peacock WF, et al
    Effect of vital sign measurement timing on Pulmonary Embolism Severity Index (PESI) and simplified PESI 30-day mortality risk determination.
    Thromb Res. 2016;141:8-10.
    PubMed     Text format    


  98. SNEEBOER MM, Hutten BA, Majoor CJ, Bel EH, et al
    Oral and inhaled corticosteroid use and risk of recurrent pulmonary embolism.
    Thromb Res. 2016;140:46-50.
    PubMed     Text format     Abstract available


  99. LJUNGQVIST M, Holmstrom M, Kieler H, Odeberg J, et al
    Cardiovascular disease and mortality after a first episode of venous thromboembolism in young and middle-aged women.
    Thromb Res. 2016;138:80-5.
    PubMed     Text format     Abstract available


  100. JORGENSEN CC, Kehlet H
    Early thromboembolic events </=1week after fast-track total hip and knee arthroplasty.
    Thromb Res. 2016;138:37-42.
    PubMed     Text format     Abstract available


  101. OLIVIER CB, Weik P, Meyer M, Weber S, et al
    TRAP-induced platelet aggregation is enhanced in cardiovascular patients receiving dabigatran.
    Thromb Res. 2016;138:63-8.
    PubMed     Text format     Abstract available


    December 2015
  102. ZHOU X, Wen W, Shan X, Qian J, et al
    MiR-28-3p as a potential plasma marker in diagnosis of pulmonary embolism.
    Thromb Res. 2015 Dec 10. pii: S0049-3848(15)30219.
    PubMed     Text format     Abstract available


  103. WANG CY, Ignjatovic V, Francis P, Cain T, et al
    Risk factors and clinical features of acute pulmonary embolism in children from the community.
    Thromb Res. 2015 Dec 10. pii: S0049-3848(15)30220.
    PubMed     Text format     Abstract available


  104. PEIMAN S, Abbasi M, Allameh SF, Asadi Gharabaghi M, et al
    Subsegmental pulmonary embolism: A narrative review.
    Thromb Res. 2015 Dec 8. pii: S0049-3848(15)30218.
    PubMed     Text format     Abstract available


  105. SUGIURA K, Kobayashi T, Ojima T
    Risks of thromboembolism associated with hormonal contraceptives related to body mass index and aging in Japanese women.
    Thromb Res. 2015 Dec 2. pii: S0049-3848(15)30216.
    PubMed     Text format     Abstract available


    November 2015
  106. CARPENTER SL, Goldman J, Sherman AK, Jeremiah Bell J, et al
    Clinical variables and Staphylococcus aureus virulence factors associated with venous thromboembolism in children.
    Thromb Res. 2015 Nov 25. pii: S0049-3848(15)30205.
    PubMed     Text format     Abstract available


  107. GROSSE SD, Nelson RE, Nyarko KA, Richardson LC, et al
    The economic burden of incident venous thromboembolism in the United States: A review of estimated attributable healthcare costs.
    Thromb Res. 2015 Nov 24. pii: S0049-3848(15)30209.
    PubMed     Text format     Abstract available


  108. CARRUZZO P, Mean M, Limacher A, Aujesky D, et al
    Association between smoking and recurrence of venous thromboembolism and bleeding in elderly patients with past acute venous thromboembolism.
    Thromb Res. 2015 Nov 24. pii: S0049-3848(15)30210.
    PubMed     Text format     Abstract available


  109. EDWIN NC, Khoury MN, Sohal D, McCrae KR, et al
    Recurrent venous thromboembolism in glioblastoma.
    Thromb Res. 2015 Nov 22. pii: S0049-3848(15)30203.
    PubMed     Text format     Abstract available


  110. HEATH OM, van Beekhuizen HJ, Nama V, Kolomainen D, et al
    Venous thromboembolism at time of diagnosis of ovarian cancer: Survival differs in symptomatic and asymptomatic cases.
    Thromb Res. 2015 Nov 22. pii: S0049-3848(15)30206.
    PubMed     Text format     Abstract available


  111. QIAN C, Yan H, Hu X, Zhang W, et al
    Increased risk of venous thromboembolism in patients with brain tumors: A systematic review and meta-analysis.
    Thromb Res. 2015 Nov 20. pii: S0049-3848(15)30194.
    PubMed     Text format     Abstract available


  112. MASOTTI L, Verdiani V, Cei M, Cioppi A, et al
    The predictive role of the Bova risk score in acute normotensive pulmonary embolism: A retrospective analysis on a real life cohort.
    Thromb Res. 2015 Nov 20. pii: S0049-3848(15)30197.
    PubMed     Text format    


  113. BACH AG, Bandzauner R, Nansalmaa B, Schurig N, et al
    Timing of pulmonary embolism diagnosis in the emergency department.
    Thromb Res. 2015 Nov 18. pii: S0049-3848(15)30195.
    PubMed     Text format    


  114. ALVARADO-MORENO JA, Hernandez-Lopez R, Chavez-Gonzalez A, Yoder MC, et al
    Endothelial colony-forming cells: Biological and functional abnormalities in patients with recurrent, unprovoked venous thromboembolic disease.
    Thromb Res. 2015 Nov 10. pii: S0049-3848(15)30181.
    PubMed     Text format     Abstract available


  115. DELATE T, Hsiao W, Kim B, Witt DM, et al
    Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.
    Thromb Res. 2015 Nov 10. pii: S0049-3848(15)30185.
    PubMed     Text format     Abstract available


  116. MWIRIGI A, McDonald V, Shapiro S, Hunt BJ, et al
    Is there benefit in extensive screening for cancer in patients with unprovoked venous thromboembolism?
    Thromb Res. 2015 Nov 6. pii: S0049-3848(15)30174.
    PubMed     Text format    


  117. SWANEPOEL AC, Pretorius E
    Prevention and follow-up in thromboembolic ischemic stroke: Do we need to think out of the box?
    Thromb Res. 2015 Nov 4. pii: S0049-3848(15)30177.
    PubMed     Text format     Abstract available


    October 2015
  118. PORTILLO J, de la Rocha IV, Font L, Braester A, et al
    Venous thromboembolism in patients with glioblastoma multiforme: Findings of the RIETE registry.
    Thromb Res. 2015 Oct 30. pii: S0049-3848(15)30175.
    PubMed     Text format     Abstract available


  119. AL-ANI F, Shariff S, Siqueira L, Seyam A, et al
    Identifying venous thromboembolism and major bleeding in emergency room discharges using administrative data.
    Thromb Res. 2015 Oct 29. pii: S0049-3848(15)30167.
    PubMed     Text format     Abstract available


  120. PESAVENTO R, Visona A, Villalta S, Vescovo G, et al
    Residual pulmonary obstruction and the risk of late complications in patients with pulmonary embolism.
    Thromb Res. 2015 Oct 28. pii: S0049-3848(15)30165.
    PubMed     Text format    


  121. MANSFIELD AS, Tafur AJ, Vulih D, Smith GL, et al
    Severe hepatic dysfunction is associated with venous thromboembolic events in phase 1 clinical trials.
    Thromb Res. 2015 Oct 20. pii: S0049-3848(15)30158.
    PubMed     Text format     Abstract available


  122. OKOROH EM, Boulet SL, George MG, Craig Hooper W, et al
    Assessing the intersection of cardiovascular disease, venous thromboembolism, and polycystic ovary syndrome.
    Thromb Res. 2015 Oct 17. pii: S0049-3848(15)30154.
    PubMed     Text format     Abstract available


  123. MEYER MR, Witt DM, Delate T, Johnson SG, et al
    Thrombophilia testing patterns amongst patients with acute venous thromboembolism.
    Thromb Res. 2015 Oct 15. pii: S0049-3848(15)30151.
    PubMed     Text format     Abstract available


  124. WITT DM, Clark NP, Martinez K, Schroeder A, et al
    Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for intracranial hemorrhage.
    Thromb Res. 2015 Oct 7. pii: S0049-3848(15)30134.
    PubMed     Text format     Abstract available


    September 2015
  125. WASSEL CL, Rasmussen-Torvik LJ, Callas PW, Denenberg JO, et al
    A genetic risk score comprising known venous thromboembolism loci is associated with chronic venous disease in a multi-ethnic cohort.
    Thromb Res. 2015 Sep 26. pii: S0049-3848(15)30127.
    PubMed     Text format     Abstract available


  126. LEE SE, Jeon YW, Yoon JH, Cho BS, et al
    Clinical outcomes of venous thromboembolism with dalteparin therapy in multiple myeloma patients.
    Thromb Res. 2015 Sep 26. pii: S0049-3848(15)30132.
    PubMed     Text format     Abstract available


  127. SUGIURA K, Kobayashi T, Ojima T
    Thromboembolism as the adverse event of combined oral contraceptives in Japan.
    Thromb Res. 2015 Sep 16. pii: S0049-3848(15)30122.
    PubMed     Text format     Abstract available


  128. GAO GY, Yang P, Liu M, Ding M, et al
    Thrombolysis for acute intermediate-risk pulmonary embolism: A meta-analysis.
    Thromb Res. 2015 Sep 12. pii: S0049-3848(15)30123.
    PubMed     Text format     Abstract available


  129. VERSO M, Chiari R, Mosca S, Franco L, et al
    Incidence of Ct scan-detected pulmonary embolism in patients with oncogene-addicted, advanced lung adenocarcinoma.
    Thromb Res. 2015 Sep 9. pii: S0049-3848(15)30117.
    PubMed     Text format    


  130. UNGPRASERT P, Tanratana P, Srivali N
    Autoimmune hemolytic anemia and venous thromboembolism: A systematic review and meta-analysis.
    Thromb Res. 2015 Sep 6. pii: S0049-3848(15)30115.
    PubMed     Text format     Abstract available


  131. LUND JL, Ostgard LS, Prandoni P, Sorensen HT, et al
    Incidence, determinants and the transient impact of cancer treatments on venous thromboembolism risk among lymphoma patients in Denmark.
    Thromb Res. 2015 Sep 5. pii: S0049-3848(15)30112.
    PubMed     Text format     Abstract available


  132. SZLAUER A, Mielimonka A, Glowacki R, Borowczyk K, et al
    Protein N-linked homocysteine is associated with recurrence of venous thromboembolism.
    Thromb Res. 2015 Sep 5. pii: S0049-3848(15)30113.
    PubMed     Text format     Abstract available


  133. KELLER K, Prochaska JH, Coldewey M, Gobel S, et al
    History of deep vein thrombosis is a discriminator for concomitant atrial fibrillation in pulmonary embolism.
    Thromb Res. 2015 Sep 3. pii: S0049-3848(15)30107.
    PubMed     Text format     Abstract available


  134. SPRONK HM, Cannegieter S, Morange P, Hackeng T, et al
    Theme 2: Epidemiology, Biomarkers, and Imaging of Venous Thromboembolism (and postthrombotic syndrome).
    Thromb Res. 2015;136 Suppl 1:S8-S12.
    PubMed     Text format    


  135. VAN DER MEIJDEN PE, Ozaki Y, Ruf W, de Laat B, et al
    Theme 1: Pathogenesis of venous thromboembolism (and post-thrombotic syndrome).
    Thromb Res. 2015;136 Suppl 1:S3-7.
    PubMed     Text format    


  136. TEN CATE-HOEK AJ, Weitz JI, Gailani D, Meijer K, et al
    Theme 3: Non-invasive management of (recurrent) venous thromboembolism (VTE) and post thrombotic syndrome (PTS).
    Thromb Res. 2015;136 Suppl 1:S13-8.
    PubMed     Text format    


    August 2015
  137. KLINE JA, Steuerwald NM, Watts JA, Courtney M, et al
    Leukocyte expression of heme oxygenase-1 [hmox1] varies inversely with severity of tricuspid regurgitation in acute pulmonary embolism.
    Thromb Res. 2015 Aug 28. pii: S0049-3848(15)30097.
    PubMed     Text format     Abstract available


  138. FOLSOM AR, Alonso A, George KM, Roetker NS, et al
    Prospective study of plasma D-dimer and incident venous thromboembolism: The Atherosclerosis Risk in Communities (ARIC) Study.
    Thromb Res. 2015 Aug 28. pii: S0049-3848(15)30101.
    PubMed     Text format     Abstract available


  139. BIANCONI D, Schuler A, Pausz C, Geroldinger A, et al
    Integrin beta-3 genetic variants and risk of venous thromboembolism in colorectal cancer patients.
    Thromb Res. 2015 Aug 28. pii: S0049-3848(15)30093.
    PubMed     Text format     Abstract available


    July 2015
  140. SINDET-PEDERSEN C, Pallisgaard JL, Olesen JB, Gislason GH, et al
    Safety and efficacy of direct oral anticoagulants compared to warfarin for extended treatment of venous thromboembolism -a systematic review and meta-analysis.
    Thromb Res. 2015 Jul 29. pii: S0049-3848(15)30073.
    PubMed     Text format     Abstract available


  141. HAN C, Zhao Y, Cheng W, Yang J, et al
    The performance of age-adjusted D-dimer cut-off in Chinese outpatients with suspected venous thromboembolism.
    Thromb Res. 2015 Jul 26. pii: S0049-3848(15)30075.
    PubMed     Text format     Abstract available


  142. BUCCIARELLI P, Maino A, Felicetta I, Abbattista M, et al
    Association between red cell distribution width and risk of venous thromboembolism.
    Thromb Res. 2015 Jul 25. pii: S0049-3848(15)30071.
    PubMed     Text format     Abstract available


  143. POSCH F, Konigsbrugge O, Zielinski C, Pabinger I, et al
    Treatment of venous thromboembolism in patients with cancer: A network meta-analysis comparing efficacy and safety of anticoagulants.
    Thromb Res. 2015 Jul 17. pii: S0049-3848(15)30062.
    PubMed     Text format     Abstract available


  144. STARIKOVA I, Jamaly S, Sorrentino A, Blondal T, et al
    Differential expression of plasma miRNAs in patients with unprovoked venous thromboembolism and healthy control individuals.
    Thromb Res. 2015 Jul 15. pii: S0049-3848(15)30057.
    PubMed     Text format     Abstract available


  145. ZOLLER B, Palmer K, Li X, Sundquist J, et al
    Family history of venous thromboembolism and risk of hospitalized thromboembolism in cancer patients: A nationwide family study.
    Thromb Res. 2015 Jul 14. pii: S0049-3848(15)30056.
    PubMed     Text format     Abstract available


  146. YANG Y, Zhang XZ, Ng HS, Fong JC, et al
    The effect of chronic liver disease on venous thromboembolism among medically managed patients in Singapore General Hospital.
    Thromb Res. 2015 Jul 6. pii: S0049-3848(15)30045.
    PubMed     Text format     Abstract available


  147. FAIZ AS, Khan I, Beckman MG, Bockenstedt P, et al
    Characteristics and Risk Factors of Cancer Associated Venous Thromboembolism.
    Thromb Res. 2015 Jul 5. pii: S0049-3848(15)30049.
    PubMed     Text format     Abstract available


    June 2015
  148. HEIT JA, Lahr BD, Ashrani AA, Petterson TM, et al
    Predictors of Venous Thromboembolism Recurrence, Adjusted for Treatments and Interim Exposures: A Population-based Case-cohort Study.
    Thromb Res. 2015 Jun 24. pii: S0049-3848(15)30041.
    PubMed     Text format     Abstract available


  149. LINDQVIST PG, von Kanel R
    How to avoid venous thromboembolism in women at increased risk - with special focus on low-risk periods.
    Thromb Res. 2015 Jun 19. pii: S0049-3848(15)30032.
    PubMed     Text format     Abstract available


  150. DEN EXTER PL, van der Hulle T, Hartmann IJ, Jimenez D, et al
    Reliability of diagnosing incidental pulmonary embolism in cancer patients.
    Thromb Res. 2015 Jun 19. pii: S0049-3848(15)30039.
    PubMed     Text format     Abstract available


  151. MINIATI M
    Perfusion lung scintigraphy for pulmonary embolism.
    Thromb Res. 2015 Jun 4. pii: S0049-3848(15)30014.
    PubMed     Text format    


    May 2015
  152. COHEN A, Jeyaindran S, Kim JY, Park K, et al
    Treating pulmonary embolism in Pacific Asia with direct oral anticoagulants.
    Thromb Res. 2015 May 27. pii: S0049-3848(15)30003.
    PubMed     Text format     Abstract available


  153. VAN ES J, Douma RA, Hezemans RE, Penaloza A, et al
    Accuracy of X-ray with perfusion scan in young patients with suspected pulmonary embolism.
    Thromb Res. 2015 May 21. pii: S0049-3848(15)00245.
    PubMed     Text format     Abstract available


  154. XIE J, Ma J, Kang P, Zhou Z, et al
    Does tranexamic acid alter the risk of thromboembolism following primary total knee arthroplasty with sequential earlier anticoagulation? A large, single center, prospective cohort study of consecutive cases.
    Thromb Res. 2015 May 21. pii: S0049-3848(15)00241.
    PubMed     Text format     Abstract available


  155. SIMKOVIC M, Vodarek P, Motyckova M, Belada D, et al
    Venous thromboembolism in patients with chronic lymphocytic leukemia.
    Thromb Res. 2015 May 20. pii: S0049-3848(15)00237.
    PubMed     Text format     Abstract available


  156. BAUDOUY D, Moceri P, Chiche O, Bouvier P, et al
    B blood group: A strong risk factor for venous thromboembolism recurrence.
    Thromb Res. 2015 May 8. pii: S0049-3848(15)00227.
    PubMed     Text format     Abstract available


  157. ARLIKAR SJ, Atchison CM, Amankwah EK, Ayala IA, et al
    Development of a new risk score for hospital-associated venous thromboembolism in critically-ill children not undergoing cardiothoracic surgery.
    Thromb Res. 2015 May 3. pii: S0049-3848(15)00208.
    PubMed     Text format     Abstract available


  158. COMEROTA AJ, Oostra C, Fayad Z, Gunning W, et al
    A histological and functional description of the tissue causing chronic postthrombotic venous obstruction.
    Thromb Res. 2015;135:882-7.
    PubMed     Text format     Abstract available


  159. KUROIWA M, Takahira N, Ujihashi Y, Miida K, et al
    Reduction in the soles of graduated compression stockings prevents falls without reducing the preventive effect for venous stasis.
    Thromb Res. 2015;135:877-81.
    PubMed     Text format     Abstract available


  160. LARSEN AC, Frokjaer JB, Fisker RV, Iyer V, et al
    Treatment-related frequency of venous thrombosis in lower esophageal, gastro-esophageal and gastric cancer--a clinical prospective study of outcome and prognostic factors.
    Thromb Res. 2015;135:802-8.
    PubMed     Text format     Abstract available


    April 2015
  161. LIPPI G, Cervellin G, Mattiuzzi C
    Red meat, processed meat and the risk of venous thromboembolism: Friend or foe?
    Thromb Res. 2015 Apr 29. pii: S0049-3848(15)00199.
    PubMed     Text format     Abstract available


  162. MARVIG CL, Verhoef TI, de Boer A, Kamali F, et al
    Quality of life in patients with venous thromboembolism and atrial fibrillation treated with coumarin anticoagulants.
    Thromb Res. 2015 Apr 25. pii: S0049-3848(15)00198.
    PubMed     Text format     Abstract available


  163. ASHRANI AA, Barsoum MK, Crusan DJ, Petterson TM, et al
    Is lipid lowering therapy an independent risk factor for venous thromboembolism? A population-based case-control study.
    Thromb Res. 2015 Apr 11. pii: S0049-3848(15)00160.
    PubMed     Text format     Abstract available


  164. LAZO-LANGNER A, Kovacs MJ, Hedley B, Al-Ani F, et al
    Screening of Patients with Idiopathic Venous Thromboembolism for Paroxysmal Nocturnal Hemoglobinuria Clones.
    Thromb Res. 2015 Apr 11. pii: S0049-3848(15)00161.
    PubMed     Text format     Abstract available


  165. HUANG W, Goldberg RJ, Cohen AT, Anderson FA, et al
    Declining Long-term Risk of Adverse Events after First-time Community-presenting Venous Thromboembolism: The Population-based Worcester VTE Study (1999 to 2009).
    Thromb Res. 2015 Apr 11. pii: S0049-3848(15)00162.
    PubMed     Text format     Abstract available


  166. FREY PM, Mean M, Limacher A, Leiss W, et al
    Quality of life after pulmonary embolism: Prospective validation of the German version of the PEmb-QoL questionnaire.
    Thromb Res. 2015 Apr 9. pii: S0049-3848(15)00153.
    PubMed     Text format     Abstract available


    March 2015
  167. DI MINNO MN, Ambrosino P, Ageno W, Rosendaal F, et al
    Natural anticoagulants deficiency and the risk of venous thromboembolism: a meta-analysis of observational studies.
    Thromb Res. 2015 Mar 13. pii: S0049-3848(15)00130.
    PubMed     Text format     Abstract available


  168. SOBIERAJ DM, Coleman CI, Pasupuleti V, Deshpande A, et al
    Comparative efficacy and safety of anticoagulants and aspirin for extended treatment of venous thromboembolism: A network meta-analysis.
    Thromb Res. 2015 Mar 4. pii: S0049-3848(15)00104.
    PubMed     Text format     Abstract available


    February 2015
  169. PENG X, Li J, Yu X, Tan R, et al
    Therapeutic effectiveness of bone marrow-derived mesenchymal stem cell administration against acute pulmonary thromboembolism in a mouse model.
    Thromb Res. 2015 Feb 12. pii: S0049-3848(15)00064.
    PubMed     Text format     Abstract available


  170. MA G, Zhang R, Wu X, Wang D, et al
    Direct factor Xa inhibitors (rivaroxaban and apixaban) versus enoxaparin for the prevention of venous thromboembolism after total knee replacement: A meta-analysis of 6 randomized clinical trials.
    Thromb Res. 2015 Feb 12. pii: S0049-3848(15)00063.
    PubMed     Text format     Abstract available


  171. LEWIS DA, Suchindran S, Beckman MG, Hooper WC, et al
    Whole blood gene expression profiles distinguish clinical phenotypes of venous thromboembolism.
    Thromb Res. 2015 Feb 7. pii: S0049-3848(15)00058.
    PubMed     Text format     Abstract available


  172. AGENO W, Samperiz A, Caballero R, Dentali F, et al
    Duration of anticoagulation after venous thromboembolism in real world clinical practice.
    Thromb Res. 2015 Feb 7. pii: S0049-3848(15)00056.
    PubMed     Text format     Abstract available


  173. HO G, Brunson A, White R, Wun T, et al
    Vena Cava Filter Use in Cancer Patients with Acute Venous Thromboembolism in California.
    Thromb Res. 2015 Feb 7. pii: S0049-3848(15)00057.
    PubMed     Text format     Abstract available


  174. PIOVELLA F, Irina Iosub D
    New anticoagulants in the management of venous thromboembolism in women.
    Thromb Res. 2015;135 Suppl 1:S5-7.
    PubMed     Text format     Abstract available


  175. NOUBOUOSSIE D, Key NS
    Sickle cell disease and venous thromboembolism in pregnancy and the puerperium.
    Thromb Res. 2015;135 Suppl 1:S46-8.
    PubMed     Text format     Abstract available


  176. MARTIN-MARTOS F, Trujillo-Santos J, Barron M, Vela J, et al
    Gender differences in cancer patients with acute venous thromboembolism.
    Thromb Res. 2015;135 Suppl 1:S12-5.
    PubMed     Text format     Abstract available


    January 2015
  177. NELSON RE, Grosse SD, Waitzman NJ, Lin J, et al
    Using multiple sources of data for surveillance of postoperative venous thromboembolism among surgical patients treated in Department of Veterans Affairs hospitals, 2005-2010.
    Thromb Res. 2015 Jan 26. pii: S0049-3848(15)00044.
    PubMed     Text format     Abstract available


  178. HOJEN AA, Gorst-Rasmussen A, Lip GY, Lane DA, et al
    Use of psychotropic drugs following venous thromboembolism in youth. A nationwide cohort study.
    Thromb Res. 2015 Jan 24. pii: S0049-3848(15)00042.
    PubMed     Text format     Abstract available


  179. ZHAO LB, Jia ZY, Lu GD, Zhu YS, et al
    Establishment of a canine model of acute pulmonary embolism with definite right ventricular dysfunction through introduced autologous blood clots.
    Thromb Res. 2015 Jan 17. pii: S0049-3848(15)00034.
    PubMed     Text format     Abstract available


  180. SANFILIPPO KM, Wang TF, Gage BF, Liu W, et al
    Improving accuracy of International Classification of Diseases codes for venous thromboembolism in administrative data.
    Thromb Res. 2015 Jan 14. pii: S0049-3848(15)00030.
    PubMed     Text format     Abstract available


  181. VALADE S, Lemiale V, Roux A, Schnell D, et al
    Life-Threatening Complications and Outcomes in Patients with Malignancies and Severe Pulmonary Embolism.
    Thromb Res. 2015 Jan 13. pii: S0049-3848(15)00027.
    PubMed     Text format     Abstract available


  182. VAN ROOY MJ, Pretorius E
    Metabolic syndrome, platelet activation and the development of transient ischemic attack or thromboembolic stroke.
    Thromb Res. 2015 Jan 9. pii: S0049-3848(15)00011.
    PubMed     Text format     Abstract available


  183. LI YD, Wang YD, Zhai ZG, Guo XJ, et al
    Relationship between echocardiographic and cardiac magnetic resonance imaging-derived measures of right ventricular function in patients with chronic thromboembolic pulmonary hypertension.
    Thromb Res. 2015 Jan 9. pii: S0049-3848(15)00010.
    PubMed     Text format     Abstract available


  184. CHUNG WS, Lin CL, Hsu WH, Kao CH, et al
    Inflammatory Bowel Disease Increases the Risks of Deep Vein Thrombosis and Pulmonary Embolism in the Hospitalized Patients: A Nationwide Cohort Study.
    Thromb Res. 2015 Jan 7. pii: S0049-3848(14)00694.
    PubMed     Text format     Abstract available


    December 2014
  185. PETTERSON TM, Marks RS, Ashrani AA, Bailey KR, et al
    Risk of site-specific cancer in incident venous thromboembolism: A population-based study.
    Thromb Res. 2014 Dec 16. pii: S0049-3848(14)00679.
    PubMed     Text format     Abstract available


  186. HACKETT CT, Ramanathan RS, Malhotra K, Quigley MR, et al
    Safety of venous thromboembolism prophylaxis with fondaparinux in ischemic stroke.
    Thromb Res. 2014 Dec 13. pii: S0049-3848(14)00677.
    PubMed     Text format     Abstract available


  187. PESAVENTO R, Amitrano M, Trujillo-Santos J, Di Micco P, et al
    Fondaparinux in the initial and long-term treatment of venous thromboembolism.
    Thromb Res. 2014 Dec 13. pii: S0049-3848(14)00666.
    PubMed     Text format     Abstract available


  188. COHEN AT, Imfeld S, Markham J, Granziera S, et al
    The use of aspirin for primary and secondary prevention in venous thromboembolism and other cardiovascular disorders.
    Thromb Res. 2014 Dec 13. pii: S0049-3848(14)00672.
    PubMed     Text format     Abstract available


  189. CHO SE, Delate T, Witt DM, Clark NP, et al
    Thromboembolic and Bleeding Outcomes of Extended Duration Low-Intensity Warfarin Following Elective Total Knee Arthroplasty.
    Thromb Res. 2014 Dec 13. pii: S0049-3848(14)00669.
    PubMed     Text format     Abstract available


  190. ARACHCHILLAGE DR, Efthymiou M, Mackie IJ, Lawrie AS, et al
    Rivaroxaban and warfarin achieve effective anticoagulation, as assessed by inhibition of TG and in-vivo markers of coagulation activation, in patients with venous thromboembolism.
    Thromb Res. 2014 Dec 13. pii: S0049-3848(14)00673.
    PubMed     Text format     Abstract available


  191. KLOK FA, Tesche C, Rappold L, Dellas C, et al
    External validation of a simple non-invasive algorithm to rule out chronic thromboembolic pulmonary hypertension after acute pulmonary embolism.
    Thromb Res. 2014 Dec 13. pii: S0049-3848(14)00649.
    PubMed     Text format     Abstract available


  192. KARMADONOVA NA, Shilova AN, Kozyreva VS, Subbotovskaya AI, et al
    Association of folate metabolism gene polymorphisms and pulmonary embolism: A case-control study of West-Siberian population.
    Thromb Res. 2014 Dec 11. pii: S0049-3848(14)00630.
    PubMed     Text format     Abstract available


  193. KJAERGAARD B, Honge JL, Magnusdottir SO, Rasmussen BS, et al
    Retrograde lung perfusion in the treatment of massive pulmonary embolism. A randomised porcine study.
    Thromb Res. 2014 Dec 6. pii: S0049-3848(14)00643.
    PubMed     Text format     Abstract available


  194. OLIE V, Fuhrman C, Chin F, Lamarche-Vadel A, et al
    Time trends in pulmonary embolism mortality in France, 2000-2010.
    Thromb Res. 2014 Dec 5. pii: S0049-3848(14)00642.
    PubMed     Text format     Abstract available


  195. DASTA JF, Pilon D, Mody SH, Lopatto J, et al
    Daily Hospitalization Costs in Patients with Deep Vein Thrombosis or Pulmonary Embolism Treated with Anticoagulant Therapy.
    Thromb Res. 2014 Dec 4. pii: S0049-3848(14)00633.
    PubMed     Text format     Abstract available


  196. YANG W, Liu Y
    Platelet-lymphocyte ratio is a predictor of venous thromboembolism in cancer patients.
    Thromb Res. 2014 Dec 3. pii: S0049-3848(14)00634.
    PubMed     Text format     Abstract available


  197. WU C, Alotaibi GS, Alsaleh K, Linkins LA, et al
    Case-fatality of recurrent venous thromboembolism and major bleeding associated with aspirin, warfarin, and direct oral anticoagulants for secondary prevention.
    Thromb Res. 2014 Dec 2. pii: S0049-3848(14)00590.
    PubMed     Text format     Abstract available


  198. KLOK FA, Huisman MV
    Thrombolysis for hemodynamically stable pulmonary embolism: Time to close the book?
    Thromb Res. 2014;134:1169-70.
    PubMed     Text format    


  199. WANG J, Wang C, Chen N, Shu C, et al
    Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and risk of venous thromboembolism: A meta-analysis.
    Thromb Res. 2014;134:1241-8.
    PubMed     Text format     Abstract available


    November 2014
  200. ZHANG S, Zhai Z, Yang Y, Zhu J, et al
    Long-term treatment with low-molecular-weight heparin prolonged the survival time for acute pulmonary embolism patients concurrent with malignancy: An observational analysis from a long-term follow-up study.
    Thromb Res. 2014 Nov 26. pii: S0049-3848(14)00624.
    PubMed     Text format     Abstract available


  201. PEREZ BOTERO J, Spoon DB, Patnaik MS, Ashrani AA, et al
    Incidence of symptomatic venous thromboembolism in patients with hemophilia undergoing joint replacement surgery: A retrospective study.
    Thromb Res. 2014 Nov 18. pii: S0049-3848(14)00619.
    PubMed     Text format     Abstract available


  202. PRINS MH, Bamber L, Cano SJ, Wang MY, et al
    Patient-reported treatment satisfaction with oral rivaroxaban versus standard therapy in the treatment of pulmonary embolism; results from the EINSTEIN PE trial.
    Thromb Res. 2014 Nov 18. pii: S0049-3848(14)00617.
    PubMed     Text format     Abstract available


  203. BOROWCZYK M, Wojtaszewska M, Lewandowski K, Gil L, et al
    The JAK2 V617F mutational status and allele burden may be related with the risk of venous thromboembolic events in patients with Philadelphia-negative myeloproliferative neoplasms.
    Thromb Res. 2014 Nov 15. pii: S0049-3848(14)00615.
    PubMed     Text format     Abstract available


  204. BAI J, Ding X, Du X, Zhao X, et al
    Diabetes is associated with increased risk of venous thromboembolism: A systematic review and meta-analysis.
    Thromb Res. 2014 Nov 14. pii: S0049-3848(14)00594.
    PubMed     Text format     Abstract available


  205. NOEL-SAVINA E, Sanchez O, Descourt R, Andre M, et al
    Tinzaparin and VKA use in patients with cancer associated venous thromboembolism: A retrospective cohort study.
    Thromb Res. 2014 Nov 6. pii: S0049-3848(14)00587.
    PubMed     Text format     Abstract available


    October 2014
  206. PENGO V, Testa S, Martinelli I, Ghirarduzzi A, et al
    Incidence of a first thromboembolic event in carriers of isolated lupus anticoagulant.
    Thromb Res. 2014 Oct 22. pii: S0049-3848(14)00569.
    PubMed     Text format     Abstract available


  207. YUSUF HR, Hooper WC, Grosse SD, Parker CS, et al
    Risk of venous thromboembolism occurrence among adults with selected autoimmune diseases: A study among a U.S. cohort of commercial insurance enrollees.
    Thromb Res. 2014 Oct 22. pii: S0049-3848(14)00568.
    PubMed     Text format     Abstract available


  208. LE ROUX PY, Robin P, Delluc A, Tardy B, et al
    Performance of 18F fluoro-2-desoxy-D-glucose positron emission tomography/computed tomography for the diagnosis of venous thromboembolism.
    Thromb Res. 2014 Oct 20. pii: S0049-3848(14)00547.
    PubMed     Text format     Abstract available


  209. LIU M, Yuan X, Qiu X, Shan X, et al
    Prognostic Role of Heart-type Fatty Acid Binding Protein in Pulmonary Embolism: a Meta-analysis.
    Thromb Res. 2014 Oct 14. pii: S0049-3848(14)00531.
    PubMed     Text format     Abstract available


  210. RIERA-MESTRE A, Becattini C, Giustozzi M, Agnelli G, et al
    Thrombolysis in hemodynamically stable patients with acute pulmonary embolism: A meta-analysis.
    Thromb Res. 2014;134:1265-1271.
    PubMed     Text format     Abstract available


    August 2014
  211. SATHLER PC, Lourenco AL, Rodrigues CR, da Silva LC, et al
    In vitro and in vivo analysis of the antithrombotic and toxicological profile of new antiplatelets N-acylhydrazone derivatives and development of nanosystems: determination of novel NAH derivatives antiplatelet and nanotechnological approach.
    Thromb Res. 2014;134:376-83.
    PubMed     Text format     Abstract available


    July 2014
  212. LIANG Z, Han R, Qu Y, Cao W, et al
    Role of prophylactic filter placement in the endovascular treatment of symptomatic thrombosis in the central veins.
    Thromb Res. 2014;134:57-62.
    PubMed     Text format     Abstract available


    May 2014
  213. ZOUBIDA TM, Azzouzi A, Bono W, Tachinante R, et al
    Thromboprophylaxis use and concordance with guidelines among medical and surgical patients in Morocco.
    Thromb Res. 2014;133:725-8.
    PubMed     Text format     Abstract available


    April 2014
  214. LEE JK, So YH, Choi YH, Park SS, et al
    Clinical course and predictive factors for complication of inferior vena cava filters.
    Thromb Res. 2014;133:538-43.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Venous Thrombosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: